Novadip Biosciences S Ais A Clinical Stage Biopharmaceutical Company Based In Mont Saint Guibertbelgiumfounded In 2013 By Denis Dufranemdphdthe Company Specializes In Developing Innovative Therapies For Tissue Regenerationparticularly For Critical Size Bone Defects And Orthopedic Conditionsnovadip Utilizes Its Proprietary 3Ma3 Technology Platformwhich Combines A 3 Dimensional Extracellular Matrix With Adipose Derived Stem Cells To Enhance Healing Processes The Company S Lead Productnvd 003Is An Autologous Therapy Aimed At Treating Severe Bone Non Union And Congenital Pseudarthrosis Of Tibiacpt A Rare Pediatric Conditionnvd 003 Is Designed To Promote Healthy Bone Formation And Restore Mobilitypotentially Preventing Amputation In Affected Childrennovadip Is Also Exploring Off The Shelf Therapies And Cell Free Mirna Exosome Therapies To Address A Wider Range Of Tissue Defectsthe Company Is Actively Engaged In Clinical Trialsdemonstrating Its Commitment To Advancing Regenerative Medicine And Addressing Unmet Medical Needs In Orthopedics
Bio International Convention 2025
United States
16 Jun 2025
2153
| Company Name | Novadip Biosciences Sa |
| Country |
Belgium
|
| Address | N/A |
| Telephone | N/A |
| N/A |
